The Cour Nanoparticle Platform (CNP) provides a novel and highly specific immune reprogramming capability which may be applied to a wide range of immune disorders.

Unmatched Breakthrough

The COUR Nanoparticle is a truly novel opportunity unmatched by current in-market and pipeline alternatives, which primarily consist of toxic immune suppressants. This platform has far-reaching implications across a wide spectrum of valuable therapeutic indications.

Cour Nanoparticle Platform
For autoimmune and allergic conditions

The Nanoparticle surface is functionalized to enhance immune uptake. The interior core can be loaded with any antigen or allergen.

Nanoarticles are programmable for any number of autoimmune conditions and allergy. Nanoparticles with target antigens may be applied to patients receiving protein/enzyme replacement or even gene therapies.